Technology transfer is the tool that helped translate a basic research discovery into products that have improved human health, and shaped our world
Sometimes, though, university discoveries require extensive development before products and services can be made available to the public. Universities can’t do this alone. In one of the major advances of the 20th century, researchers at Stanford and UC San Francisco learned to clone genes in the early 1970s, but it wasn’t until 1982 that the first new drug based on this discovery – human insulin – was approved for human use. Turning the research discovery into a useful product required significant investment and further development by a private company partner, Genentech. Because companies invested in developing this university discovery, today literally hundreds of new health care products are in use, and a new industry – biotechnology – adds tremendous value to the world’s economy.